MBOAT4 and obesity due to melanocortin 4 receptor deficiency: Consequently, there has been considerable interest in targeting the GHS receptor or inhibiting GOAT as an anti-obesity therapy, for example, utilizing antagonists, inverse agonists, ghrelin vaccines and GOAT enzyme inhibitors (56, 57).